Neurology
RSSArticles
-
Neurology Alert - Full December 2010 Issue in PDF
-
Is It a Coincidence that Death Rhymes with Breath?
Pulmonary function can help predict cardiovascular death risk in individuals in the intermediate-risk group of Framingham Risk Scores. -
Dabigatran Etexilate mesylate Capsules (Pradaxa®)
Dabigatran is indicated for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. -
Lifetime Follow-up Care after Childhood Cancer
Lifetime surveillance is required after successful treatment of childhood cancers, since up to 75% of survivors develop serious complications and other late effects. -
Should Everyone Be on Fish Oils?
Marine n-3 PUFAs act as pleiotropic agents on the cardiovascular system with a diverse range of effects most of which are beneficial for patients with known cardiovascular disease and possibly, they may even have beneficial effects with regard to the primary prevention of cardiovascular disease. -
Clinical Briefs By Louis Kuritzky, MD
Since the publication of the allhat trial, clinicians have progressively relied upon diuretic-based regimens to manage hypertension (HTN). -
Internal Medicine Alert - Full November 29, 2010 Issue in PDF
-
Black and White Differences in Hemoglobin A1c Levels
American non-Hispanic black persons had higher HbA1c levels than white persons at all levels of glycemia, and this difference increased as glucose intolerance worsened. -
Pharmacology Watch
FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions. -
Internal Medicine Alert - Full November 15, 2010 Issue in PDF